153 related articles for article (PubMed ID: 37746942)
1. A novel clinical tool and risk stratification system for predicting the event-free survival of neuroblastoma patients: A TARGET-based study.
Li M; Duan X; Li C; You D; Liu L
Medicine (Baltimore); 2023 Sep; 102(38):e34925. PubMed ID: 37746942
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a nomogram for predicting survival in intermediate- and high-risk neuroblastoma of the Children's Oncology Group risk stratification.
Feng L; Kan Y; Wang W; Wang C; Zhang H; Xie P; Yang J
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16377-16390. PubMed ID: 37702807
[TBL] [Abstract][Full Text] [Related]
3. Construction of a Prognostic Nomogram Based on Autophagy-Related Genes for Children With Neuroblastoma.
Ye G; Wang Y
Evol Bioinform Online; 2022; 18():11769343221120960. PubMed ID: 36046056
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a nomogram based on common biochemical indicators for survival prediction of children with high-risk neuroblastoma: A valuable tool for resource-limited hospitals.
Wu R; Li X; Chen Z; Shao Q; Zhang X; Tang W; Hu B
BMC Pediatr; 2023 Aug; 23(1):426. PubMed ID: 37633889
[TBL] [Abstract][Full Text] [Related]
5. A practical nomogram and risk stratification system for predicting survival outcomes in neuroblastoma patients: a SEER population-based study.
Zhuo X; Xia L; Tang W; He W
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12285-12296. PubMed ID: 37430162
[TBL] [Abstract][Full Text] [Related]
6. A prognostic nomogram for neuroblastoma in children.
Li X; Meng Y
PeerJ; 2019; 7():e7316. PubMed ID: 31338261
[TBL] [Abstract][Full Text] [Related]
7. A novel nomogram for predicting post-recurrence survival in recurrent neuroblastoma patients.
Chen WM; Fang YY; Lin P; Bai JX; Fang YF; Zhang B
Am J Cancer Res; 2023; 13(6):2254-2268. PubMed ID: 37424797
[TBL] [Abstract][Full Text] [Related]
8. A Novel Online Nomogram Established with Five Features before Surgical Resection for Predicating Prognosis of Neuroblastoma Children: A Population-Based Study.
Zhou Y; Gao J
Technol Cancer Res Treat; 2023; 22():15330338221145141. PubMed ID: 36604997
[No Abstract] [Full Text] [Related]
9. A nomogram for predicting recurrence-free survival of intermediate and high-risk neuroblastoma.
Sun Q; Chen Y; Jin Q; Yuan X
Eur J Pediatr; 2022 Dec; 181(12):4135-4147. PubMed ID: 36149505
[TBL] [Abstract][Full Text] [Related]
10. Application of clinical nomograms to predicting overall survival and event-free survival in multiple myeloma patients: Visualization tools for prognostic stratification.
Xu J; Zuo Y; Sun J; Zhou M; Dong X; Chen B
Front Public Health; 2022; 10():958325. PubMed ID: 36324453
[TBL] [Abstract][Full Text] [Related]
11. Integration of clinical characteristics and molecular signatures of the tumor microenvironment to predict the prognosis of neuroblastoma.
Cheng H; Zhang L; Yang S; Ren Q; Chang S; Jin Y; Mou W; Qin H; Yang W; Zhang X; Zhang W; Wang H
J Mol Med (Berl); 2023 Nov; 101(11):1421-1436. PubMed ID: 37712965
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a novel nomogram for predicting overall survival patients with neuroblastoma.
Zhao JD; Lu XY; Chen TP; Duan XL; Zuo W; Sai K; Zhu LR; Gao Q
Eur J Surg Oncol; 2024 Apr; 50(6):108321. PubMed ID: 38598875
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a novel stemness-related prognostic model for neuroblastoma using integrated machine learning and bioinformatics analyses.
Xia Y; Wang C; Li X; Gao M; Hogg HDJ; Tunthanathip T; Hulsen T; Tian X; Zhao Q
Transl Pediatr; 2024 Jan; 13(1):91-109. PubMed ID: 38323183
[TBL] [Abstract][Full Text] [Related]
14. Risk stratification system and web-based nomogram constructed for predicting the overall survival of primary osteosarcoma patients after surgical resection.
Gao B; Wang MD; Li Y; Huang F
Front Public Health; 2022; 10():949500. PubMed ID: 35991065
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Five-Gene Signature Derived From MYCN Amplification and Establishment of a Nomogram for Predicting the Prognosis of Neuroblastoma.
Xia Y; Li X; Tian X; Zhao Q
Front Mol Biosci; 2021; 8():769661. PubMed ID: 34950701
[No Abstract] [Full Text] [Related]
16. Predicting event-free survival after induction of remission in high-risk pediatric neuroblastoma: combining
Feng L; Yang X; Wang C; Zhang H; Wang W; Yang J
Pediatr Radiol; 2024 May; 54(5):805-819. PubMed ID: 38492045
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and novel predictive models for metastatic neuroblastoma in children.
Lin Y; Wang Z; Liu S
Eur J Surg Oncol; 2023 Dec; 49(12):107110. PubMed ID: 37862722
[TBL] [Abstract][Full Text] [Related]
18. The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
Moroz V; Machin D; Hero B; Ladenstein R; Berthold F; Kao P; Obeng Y; Pearson ADJ; Cohn SL; London WB
Pediatr Blood Cancer; 2020 Aug; 67(8):e28359. PubMed ID: 32472746
[TBL] [Abstract][Full Text] [Related]
19. An Optimal Radiomics Nomogram Based on
Feng L; Zhang S; Lu X; Yang X; Kan Y; Wang C; Zhang H; Wang W; Yang J
Acad Radiol; 2023 Oct; 30(10):2309-2320. PubMed ID: 37393177
[TBL] [Abstract][Full Text] [Related]
20. Identification and Validation of Inflammatory Response-Related Gene Signatures to Predict the Prognosis of Neuroblastoma.
Song J; Song L; Lv Z; Liu J; Feng X; Zhang S; Song A
Int J Genomics; 2022; 2022():2417351. PubMed ID: 35535346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
